GRANULES INDIA
Back to Balance Sheet
|
GRANULES INDIA Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹3.04 Cr | ₹3.04 Cr | ₹3.04 Cr | ₹0.99 Cr | ₹0.99 Cr |
What is the latest Contingent Liabilities ratio of GRANULES INDIA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹3.04 Cr |
| Mar2024 | ₹3.04 Cr |
| Mar2023 | ₹3.04 Cr |
| Mar2022 | ₹0.99 Cr |
| Mar2021 | ₹0.99 Cr |
How is Contingent Liabilities of GRANULES INDIA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3.04 Cr | 0.00 | |
| Mar2024 | ₹3.04 Cr | 0.00 | |
| Mar2023 | ₹3.04 Cr | 206.14 | |
| Mar2022 | ₹0.99 Cr | 0.00 | |
| Mar2021 | ₹0.99 Cr | - | |
Compare Contingent Liabilities of peers of GRANULES INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GRANULES INDIA | ₹17,075.9 Cr | 3.8% | 16.6% | 42.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹388,680.0 Cr | -2.9% | -8.9% | -3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,817.0 Cr | 1.2% | 4.2% | 8.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹139,297.0 Cr | -1.7% | -3.6% | 27.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,828.0 Cr | 6.8% | 1.3% | 13.2% | Stock Analytics | |
| CIPLA | ₹104,588.0 Cr | 5.4% | 3.1% | -13.6% | Stock Analytics | |
GRANULES INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GRANULES INDIA | 3.8% |
16.6% |
42.9% |
| SENSEX | -2.3% |
3.3% |
-2.4% |
You may also like the below Video Courses